Emily Burrows

1.0k total citations
13 papers, 835 citations indexed

About

Emily Burrows is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Emily Burrows has authored 13 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Emily Burrows's work include Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Brain Metastases and Treatment (4 papers). Emily Burrows is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Brain Metastases and Treatment (4 papers). Emily Burrows collaborates with scholars based in United States and Italy. Emily Burrows's co-authors include Lisa A. Carey, Charles M. Perou, Hope S. Rugo, Eric P. Winer, Madlyn Ferraro, Allison M. Deal, Timothy J. Hobday, Andres Forero‐Torres, Erica L. Mayer and X. Cynthia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Emily Burrows

10 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Burrows United States	6	636	375	350	204	83	13	835
Giuseppina Rosaria Rita Ricciardi Italy	16	588 0.9×	293 0.8×	483 1.4×	313 1.5×	53 0.6×	42	947
Marit Synnestvedt Norway	14	546 0.9×	419 1.1×	152 0.4×	259 1.3×	63 0.8×	19	778
Cynthia R. Osborne United States	12	629 1.0×	291 0.8×	270 0.8×	293 1.4×	37 0.4×	30	882
Ijeoma Adaku Umelo Belgium	10	372 0.6×	375 1.0×	315 0.9×	524 2.6×	55 0.7×	16	869
Jean Powers Canada	9	330 0.5×	209 0.6×	265 0.8×	420 2.1×	53 0.6×	12	748
Amal Arnaout United States	4	504 0.8×	232 0.6×	356 1.0×	119 0.6×	44 0.5×	4	673
Maria Trypaki Greece	14	517 0.8×	319 0.9×	438 1.3×	366 1.8×	118 1.4×	26	869
Fara Brasó‐Maristany Spain	10	474 0.7×	284 0.8×	290 0.8×	230 1.1×	43 0.5×	58	711
Bárbara Angulo Spain	13	386 0.6×	203 0.5×	334 1.0×	374 1.8×	107 1.3×	17	723
Leanne G. Ahronian United States	9	290 0.5×	226 0.6×	174 0.5×	198 1.0×	131 1.6×	18	524

Countries citing papers authored by Emily Burrows

Since Specialization

Citations

This map shows the geographic impact of Emily Burrows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Burrows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Burrows more than expected).

Fields of papers citing papers by Emily Burrows

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Burrows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Burrows. The network helps show where Emily Burrows may publish in the future.

Co-authorship network of co-authors of Emily Burrows

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Burrows. A scholar is included among the top collaborators of Emily Burrows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Burrows. Emily Burrows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ewend, Matthew G., Allison M. Deal, Bárbara Adamo, et al.. (2019). Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases. UNC Libraries.

Carey, Lisa A., Hope S. Rugo, P. Kelly Marcom, et al.. (2012). TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer. Journal of Clinical Oncology. 30(21). 2615–2623. 392 indexed citations

Meyers, Michael O., Nancy Klauber‐DeMore, David W. Ollila, et al.. (2011). Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer. Annals of Surgical Oncology. 18(10). 2851–2857. 81 indexed citations

Adamo, Bárbara, Allison M. Deal, Emily Burrows, et al.. (2011). Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases. Breast Cancer Research. 13(6). R125–R125. 84 indexed citations

Sweeting, Raeshell S., Nancy Klauber‐DeMore, Michael O. Meyers, et al.. (2011). Young Women with Locally Advanced Breast Cancer Who Achieve Breast Conservation after Neoadjuvant Chemotherapy Have a Low Local Recurrence Rate. The American Surgeon. 77(7). 850–855. 21 indexed citations

Adamo, Bárbara, Emily Burrows, Karen Fritchie, et al.. (2011). AlphaB-crystallin (aBC) expression in breast cancer brain metastases (BM) and primary breast cancer (pBC) with eventual BM and association with outcome.. Journal of Clinical Oncology. 29(15_suppl). 2041–2041.

Burrows, Emily. (2010). Termination of Sound Recording Copyrights & the Potential Unconscionability of Work for Hire Clauses. 30(1). 101.

Anders, Carey K., Allison M. Deal, C. Ryan Miller, et al.. (2010). The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer. 117(8). 1602–1611. 120 indexed citations

Adamo, Bárbara, Emily Burrows, Karen Fritchie, et al.. (2010). Abstract P1-14-01: Phosphatidylinositol 3-Kinase (PI3K) Pathway Activation in Breast Cancer Brain Metastases. Cancer Research. 70(24_Supplement). P1–14. 1 indexed citations

10.

Meng, Huan Xin, Emily Burrows, Karen Fritchie, et al.. (2010). The prognostic contribution of intrinsic breast cancer subtype, race, and age among patients with brain metastases.. Journal of Clinical Oncology. 28(15_suppl). 1027–1027. 1 indexed citations

11.

Moore, David, et al.. (2009). Differential timing and patterns of recurrence among breast cancer subtypes. Journal of Clinical Oncology. 27(15_suppl). 1076–1076. 1 indexed citations

12.

Deal, Allison M., et al.. (2009). Improved clinical response from neoadjuvant taxane chemotherapy across breast cancer subtypes. Journal of Clinical Oncology. 27(15_suppl). 576–576. 1 indexed citations

13.

Carey, LA, Hope S. Rugo, P. Kelly Marcom, et al.. (2008). TBCRC 001: EGFR inhibition with cetuximab added to carboplatin in metastatic triple-negative (basal-like) breast cancer. Journal of Clinical Oncology. 26(15_suppl). 1009–1009. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact